Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Brabender, J; Danenberg, KD; Metzger, R; Schneider, PM; Park, JM; Salonga, D; Holscher, AH; Danenberg, PV
   Epidermal growth factor receptor and HER2-neu mRNA expression in non-smallcell lung cancer is correlated with survival
   CLINICAL CANCER RESEARCH
   
   J. Brabender et al., "Epidermal growth factor receptor and HER2-neu mRNA expression in non-smallcell lung cancer is correlated with survival", CLIN CANC R, 7(7), 2001, pp. 1850-1855
2. Paik, S; Park, C
   HER-2 and choice of adjuvant chemotherapy in breast cancer
   SEMINARS IN ONCOLOGY
   
   S. Paik e C. Park, "HER-2 and choice of adjuvant chemotherapy in breast cancer", SEMIN ONCOL, 28(4), 2001, pp. 332-335
3. Matheson, SL; McNamee, J; Jean-Claude, BJ
   Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: A novel tumor targeting strategy
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   S.L. Matheson et al., "Design of a chimeric 3-methyl-1,2,3-triazene with mixed receptor tyrosine kinase and DNA damaging properties: A novel tumor targeting strategy", J PHARM EXP, 296(3), 2001, pp. 832-840
4. Jarvinen, TAH; Liu, ET
   Effects of HER-2/neu on chemosensitivity of tumor cells
   DRUG RESISTANCE UPDATES
   
   T.A.H. Jarvinen e E.T. Liu, "Effects of HER-2/neu on chemosensitivity of tumor cells", DRUG RESIST, 3(6), 2000, pp. 319-324
5. Tsai, CM; Chang, KT; Li, L; Perng, RP; Yang, LY
   Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells
   JAPANESE JOURNAL OF CANCER RESEARCH
   
   C.M. Tsai et al., "Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells", JPN J CANC, 91(2), 2000, pp. 213-222
6. Nguyen, DM; Chen, A; Mixon, A; Schrump, DS
   Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin
   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
   
   D.M. Nguyen et al., "Sequence-dependent enhancement of paclitaxel toxicity in non-small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin", J THOR SURG, 118(5), 1999, pp. 908-915
7. Lopez-Guerrero, JA; Bolufer-Gilabert, P; Vera-Sempere, FJ; de la Concha, IM; Barragan-Gonzalez, E
   C-erbB-2 expression and its relationship with ploidy, p53 abnormalities and epidermal growth factor receptor content in human non-small cell lung cancer
   CLINICA CHIMICA ACTA
   
   J.A. Lopez-Guerrero et al., "C-erbB-2 expression and its relationship with ploidy, p53 abnormalities and epidermal growth factor receptor content in human non-small cell lung cancer", CLIN CHIM A, 285(1-2), 1999, pp. 105-120
8. MOUSSEAU M
   CHEMOTHERAPY OF BRAIN-TUMORS - BIOLOGICAL RATIONALE OF ITS LOW EFFICACY
   Bulletin du cancer
   
   M. Mousseau, "CHEMOTHERAPY OF BRAIN-TUMORS - BIOLOGICAL RATIONALE OF ITS LOW EFFICACY", Bulletin du cancer, 81(5), 1994, pp. 414-424